Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Other financing activities (2021 - 2025)

Definitive Healthcare filings provide 5 years of Other financing activities readings, the most recent being $3.3 million for Q4 2025.

  • On a quarterly basis, Other financing activities changed N/A to $3.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.8 million, a 6.0% decrease, with the full-year FY2025 number at $4.9 million, changed N/A from a year prior.
  • Other financing activities hit $3.3 million in Q4 2025 for Definitive Healthcare, up from $1.1 million in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $5.8 million in Q1 2024 to a low of $126000.0 in Q1 2021.
  • Median Other financing activities over the past 5 years was $1.3 million (2021), compared with a mean of $1.7 million.
  • Biggest five-year swings in Other financing activities: soared 930.95% in 2022 and later crashed 71.51% in 2023.
  • Definitive Healthcare's Other financing activities stood at $2.1 million in 2021, then skyrocketed by 33.07% to $2.8 million in 2022, then plummeted by 72.24% to $782000.0 in 2023, then crashed by 36.7% to $495000.0 in 2024, then surged by 564.24% to $3.3 million in 2025.
  • The last three reported values for Other financing activities were $3.3 million (Q4 2025), $1.1 million (Q3 2025), and $609000.0 (Q2 2025) per Business Quant data.